GDF15 and dilated cardiomyopathy: sST2 independently predicted all-cause mortality in non-ischemic, dilated cardiomyopathy during a follow-up of 7 years, but it was inferior to growth differentiation factor-15 (GDF-15) for the prediction of fatal arrhythmic events in this patient population (17).